Results are similar to prior studies using pharmacologic or non-cell-specific gene therapy methods to upregulate SIRT1, which consistently demonstrated RGC neuroprotection in optic neuritis without suppression of optic nerve inflammation [18,19,20,27]. This evidence concerns the gene SIRT1 and optic neuritis.